Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026 Research and Development Diabetes, Ondibta, Sandoz

Sandoz has announced that its Ondibta (insulin glargine) has received approval from the European Commission (EC) for the treatment of …
News

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026 Research and Development Complement Therapeutics, FDA, Opthalmology, geographic atrophy

Complement Therapeutics has announced that CTx001, its gene therapy treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD), …
News

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026 Research and Development Iktos, Oncology, Pierre Fabre Laboratories

Pierre Fabre Laboratories and Iktos have announced a new collaboration intended to discover and develop new small-molecule drug candidates for …
News

European Medicines Agency recommended 104 medicines for approval in 2025

January 20, 2026 Research and Development European Medicines Agency, Rare Diseases

The European Medicines Agency (EMA) has announced data from 2025 showing that over the course of the year it recommended …
News

Biogen’s high-dose Spinraza regimen receives European Commission approval for spinal muscular atrophy

January 19, 2026 Research and Development Biogen, Neurology, Spinraza, spinal muscular atrophy

Biogen’s Spinraza (nusinersen) has received approval from the European Commission (EC) as a new high-dose regimen for the treatment of …
News

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026 Research and Development Bio-Sourcing, Oncology, Zerion Pharma, breast cancer

Bio-Sourcing and Zerion Pharma have announced that their collaboration to develop an oral form of the monoclonal antibody trastuzumab for …
News

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026 Research and Development Biocartis, Mayo Clinic, Oncology, breast cancer

Biocartis has announced a research collaboration with Mayo Clinic in the US, aiming to develop an accelerated sample-to-answer test resulting …
News

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026 Research and Development Blue Earth Therapeutics, Oncology, prostate cancer

Blue Earth Therapeutics, a clinical-stage company specialising in targeted radiotherapeutics, has announced that the first UK patient has received its …
News

Medicus Pharma’s Teverelix shows positive efficacy and safety in premenopausal women

January 13, 2026 Research and Development Endocrinology, Medicus Pharma, Teverelix

Medicus Pharma’s Teverelix has demonstrated long-lasting hormone suppression, as well as a favourable safety profile, in new study data. Teverelix …
News

Teva’s Ajovy significantly reduces migraine in children and adolescents

January 12, 2026 Research and Development Neurology, Teva, ajovy, migraine

Teva’s Ajovy (fremanezumab) has demonstrated significant reduction in monthly migraine and headache days in children and adolescents with episodic migraine …
News

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026 Research and Development Gates Foundation, Just – Evotec Biologics

Evotec has announced that its subsidiary, Just – Evotec Biologics, has received a Gates Foundation grant with the goal of …
News

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026 Research and Development FDA, Gastrointestinal tract, Johnson & Johnson

Johnson & Johnson has announced the submission of its Ottava Robotic Surgical System for De Novo classification from the US …
News

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026 Research and Development Psychiatry, ea pharma, schizophrenia

EA Pharma, a subsidiary of Eisai, has announced the initiation of a phase 3 clinical trial of evenamide, a schizophrenia …
News

Mavatar announces research collaboration with Sobi

January 6, 2026 Research and Development Immunology, Mavatar, Rare Diseases, sobi

Mavatar has announced the initiation of a non-clinical research collaboration with Sobi, using Mavatar’s technology to generate data insights into …
News

DemeRx announces completion of alcohol use disorder treatment trial

January 5, 2026 Research and Development DemeRx, alcohol use disorder

DemeRx has announced the successful completion of its phase 1 study of DMX-1001 (oral noribogaine) in the treatment of alcohol …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026